OMX Copenhagen PI
1.199,35
PKT
+23,69
PKT
+2,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.02.16 | Novo Nordisk Sell | UBS AG | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.16 | Novo Nordisk Neutral | UBS AG | |
| 04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.16 | Novo Nordisk verkaufen | S&P Capital IQ | |
| 01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
| 01.02.16 | Novo Nordisk Neutral | UBS AG | |
| 01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 14.01.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 08.01.16 | Novo Nordisk overweight | Barclays Capital | |
| 07.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 06.01.16 | Novo Nordisk overweight | Morgan Stanley | |
| 10.12.15 | Novo Nordisk Neutral | BNP PARIBAS | |
| 02.12.15 | Novo Nordisk overweight | Morgan Stanley | |
| 01.12.15 | Novo Nordisk Halten | Independent Research GmbH | |
| 30.11.15 | Novo Nordisk Hold | Deutsche Bank AG | |
| 25.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.11.15 | Novo Nordisk Neutral | UBS AG | |
| 20.11.15 | Novo Nordisk buy | Citigroup Corp. | |
| 20.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 17.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 05.11.15 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.11.15 | Novo Nordisk buy | Citigroup Corp. | |
| 02.11.15 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 30.10.15 | Novo Nordisk overweight | Morgan Stanley | |
| 30.10.15 | Novo Nordisk Reduce | HSBC | |
| 29.10.15 | Novo Nordisk verkaufen | S&P Capital IQ | |
| 29.10.15 | Novo Nordisk buy | Citigroup Corp. | |
| 26.10.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.10.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 19.10.15 | Novo Nordisk Neutral | UBS AG | |
| 15.10.15 | Novo Nordisk Neutral | UBS AG | |
| 15.10.15 | Novo Nordisk Hold | Commerzbank AG | |
| 28.09.15 | Novo Nordisk buy | Citigroup Corp. |